When the GUARD-AF study had first started enrolling patients in 2019, researchers had planned to include 52,000 patients. The Covid-19 pandemic dashed those plans, and the study ended up ...

The analysis period corresponded to the initial launch of the Zio monitor and included 14-day prescriptions between May 2022 and September 2023, comprising 7,433 Zio monitors and 1,336,391 Zio XT ...

This note discusses the important advancements of the iRhythm (IRTC) Zio Monitor. iRhythm is a constituent of the Robo Global Healthcare Technology and Innovation Index (HTEC).

iRhythm's Zio XT wearable heart monitor raises AFib diagnoses by 52%, but doesn't reduce stroke hospitalisations in GUARD-AF trial.

Ambulatory cardiac monitors (ACM) enable heart rhythm monitoring for various durations, including Holter monitors (0–48 hours), long-term continuous monitoring (LTCM, 3–14 days), and external ...

VitalConnect raises $100M for heart monitor patch. ... Unlike rival devices such as iRhythm’s Zio, VitalConnect’s product provides real-time monitoring of vital signs including respiratory rate.

Primary care screening using heart monitor patch that continuously records heartbeat for 14 days increased atrial fibrillation diagnoses by 52% compared to usual care, as well as the use of oral ...

Screening for atrial fibrillation (AF) using a wearable heart monitor for 2 weeks can identify older adults with this potentially dangerous abnormal heart rhythm, but does not prevent subsequent ...

The new Zio LTCM service demonstrated fewer early wear terminations, with data showing a wear time of less than 48 hours in 1.1% of Zio monitor services compared to 2.8% for Zio XT service.

Ambulatory cardiac monitors (ACM) enable heart rhythm monitoring for various durations, including Holter monitors (0–48 hours), long-term continuous monitoring (LTCM, 3–14 days), and external ...